AI-methods-precision-therapies.png

AI Methods for Precision Therapies

Developing AI methods for heterogeneity-aware precision therapies.

Overview

Our hope is that building tumor ecosystem representations and understanding the associated heterogeneity will allow us to predict disease progression and treatment response.

aiscr.jpg

PROMETEX: metabolically-instructed therapy selection for prostate cancer

Together with Prof. Marianna Kruithof-de Julio from the Urogenus lab of the University of Bern and Prof. Theodore Alexandrov, Team Leader at EMBL Heidelberg, we are working on combining patient-derived organoids with single-cell metabolomics towards developing metabolically-instructed personalized prostate cancer therapies. Our project PROMETEX was recently awarded a Sinergia grant from the Swiss National Science Foundation.

Contributors

Related projects

modeling-spatial-heterogeneity-tumor-microenvironment.png

Modeling Spatial Heterogeneity of the Tumor Microenvironment

Combining spatial single-cell omics with AI to model the complexity of the tumor micorenvironment and enable novel spatial biomarker discovery.
modeling-4d-genome.png

Modeling the 4D Genome

Modeling the 4D genome with deep learning and stochastic simulations.
quantifying-biological-heterogeneity-single-cell-data.png

Quantifying Biological Heterogeneity from Single-cell Data

Understanding, modeling and quantifying different sources of heterogeneity from single-cell measurements.
AI-Single-Cell-Research.png

AI for Single-cell Research

Understanding spatiotemporal heterogeneity across different scales of biological organization.